Related Experiment Video
Updated: Jan 17, 2026

Author Spotlight: Understanding Retinal Vessel Resilience and Disease Progression
Published on: January 12, 2024
Longitudinal Neural and Microvascular Changes in Type 2 Diabetic Patients Without Retinopathy: A 2-Year Prospective
Yiran Fan1, Lingyi Li1, Xinyan Wu1
1State Key Laboratory of Ophthalmology, Zhongshan Ophthalmic Center, Sun Yat-sen University, Guangdong Provincial Key Laboratory of Ophthalmology and Visual Science, Guangdong Provincial Clinical Research Center for Ocular Diseases, Guangzhou, China.
Type 2 diabetes patients without retinopathy show faster ganglion cell loss than controls, suggesting neurodegeneration precedes microvascular changes. Monitoring ganglion cell-inner plexiform layer thickness (GCIPLT) is vital even without retinopathy.
Area of Science:
- Ophthalmology
- Endocrinology
- Neuroscience
Background:
- Type 2 diabetes mellitus (T2DM) is a systemic disease with significant ocular complications.
- Diabetic retinopathy (DR) is a major cause of vision loss in T2DM patients.
- Early detection of retinal changes in T2DM is crucial for timely intervention.
Purpose of the Study:
- To compare 2-year longitudinal changes in macular ganglion cell-inner plexiform layer thickness (GCIPLT) and superficial capillary plexus (SCP) vessel density.
- To assess these changes in T2DM patients without retinopathy (non-DR) versus healthy controls.
Main Methods:
- Prospective observational cohort study involving T2DM patients without retinopathy and age/sex-matched healthy controls.
- Macular GCIPLT, retinal thickness (RT), and SCP vessel density were measured at baseline and 2-year follow-up.
- Linear mixed-effects models were used to compare longitudinal changes between groups.
Main Results:
- Significant GCIPLT reduction occurred in the non-DR group (-0.229 µm/y), approximately 5-fold faster than in controls.
- Adjusted longitudinal rates showed accelerated RT and GCIPLT decline in non-DR patients compared to controls.
- No significant differences in longitudinal SCP vessel density changes were observed between the groups.
Conclusions:
- Neurodegenerative changes, indicated by GCIPLT thinning, may precede microvascular alterations in T2DM patients without retinopathy.
- Monitoring GCIPLT is essential for long-standing diabetes management, even in the absence of clinical retinopathy.
More Related Videos
07:41Behavioral Assessment of Visual Function via Optomotor Response and Cognitive Function via Y-Maze in Diabetic Rats
Published on: October 23, 2020
10:07Studying Diabetes Through the Eyes of a Fish: Microdissection, Visualization, and Analysis of the Adult tgfli:EGFP Zebrafish Retinal Vasculature
Published on: December 26, 2017
Related Concept Videos
Diabetes Mellitus: Type 2 and Gestational
Diabetes Mellitus: Overview and Type I Subtype
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Pathophysiology of Diabetes
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation
Diabetes: Symptoms, Diagnosis, and Complications
Carbohydrate Metabolism
Starch accounts for approximately 60% of the carbohydrates consumed by humans. Since amylase enzymes cannot function in the stomach's acidic environment, starch can only be digested in the mouth and small intestine. Simple sugars are found naturally in milk and fruits in...